1 |
O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689-92.
DOI
ScienceOn
|
2 |
Folkman J, Beckner K. Angiogenesis Imaging. Acad Radiol 2000;7:783-5.
DOI
ScienceOn
|
3 |
Brasch RC, Li KC, Husband JE, et al. In vivo monitoring of tumour angiogenesis with MR imaging. Acad Radiol 2000;7:812-23.
DOI
ScienceOn
|
4 |
Weissleder R and Mahmood U. Molecular imaging. Radiology 2001;219:3160-330.
|
5 |
이경한. 분자영상: 핵의학적 접근. 대한의협회지 2004;47:119-26.
|
6 |
Haubner R, Wester HJ, Reuning U, et al. Radiolabeled v 3 integrin antagonists: A new calss of tracers for tumor imaging. J Nucl Med 1999;40:1061-71.
PUBMED
|
7 |
Haubner R, Wester HJ, Weber WA, et al. Noninvasive imaging of v 3 integrin expression using 18F-labeled RGD containing glycopeptide and positron emission tomography. Cancer Res 2001;61:1781-5.
PUBMED
|
8 |
Lee K-H, Song SH, Paik J-Y, et al. Specific Endothelial binding and tumor uptake of radiolabeled angiostatin. Eur J Nucl Med Mol Imaging 2003;30:1032-37.
DOI
PUBMED
|
9 |
Casey R, Jaffe M, Li WW, Li VW, Tsakayannis D: Market Study of Angiogenesis-Dependent Diseases: Classification and Sizing of the Potential Market for the Pharmaceutical Industry in the United States and in the European Union. The Angiogenesis Foundation, Cambridge. pp 7-20, 1998.
|
10 |
Weidner N, Semple JP, Welch WR. Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
|
11 |
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
DOI
PUBMED
ScienceOn
|
12 |
Weber WA, Haubner R, Vabuliene E, Kuhnast B, Wester HJ, Schwaiger M. Tumor angiogenesis targeting using imaging agents. Q J Nucl Med 2001;45:179-82.
PUBMED
|
13 |
Herschman HR. Molecular imaging: Looking at problems, seeing solutions. Science 2003;302:605-8.
DOI
PUBMED
ScienceOn
|
14 |
Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997;390:404-7.
DOI
ScienceOn
|
15 |
Yang DJ, Kim KD, Schechter NR, et al. Assessment of antiangiogenic effect using -EC-endostatin. Cancer Biother Radiopharm 2002;17:233-45.
DOI
ScienceOn
|
16 |
Miles KA, Charbasabgave JC, Lee FT, Fishman EK, Horton K, Lee TY. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000;7:840-50.
DOI
ScienceOn
|
17 |
Janssen ML, Oyen WJ, Dijkgraaf I, et al. Tumor targeting with radiolabeled v 3 integrin binding peptides in a nude mouse model. Cancer Res 2002;62:6146-51.
PUBMED
|
18 |
Harris AL. Antiangiogenesis for cancer therapy. Lancet 1997;349:SII13-5.
PUBMED
|
19 |
Costouros NG, Diehn FE, Libutti SK. Molecular imaging of tumor angiogenesis. J Cell Biochem Suppl 2002;39:72-8.
PUBMED
|